Comparing clot-busting drugs for lung infections
Part of Lungs & breathing clinical trials.
This trial tests two combinations of medicines for people with infected fluid around the lung that isn't draining well through a chest tube. The goal is to see which combination works better to clear the infection and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a confirmed lung infection (empyema or complicated parapneumonic effusion) with poor fluid drainage (less than 150 ml in 24 hours) after a chest tube is placed
- You have at least two signs of infection (like fever, high CRP or white blood cell count, or complex fluid seen on ultrasound)
- Your infected fluid meets one or more lab criteria (e.g., looks like pus, has high LDH, low pH, low glucose, or positive culture)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a lower dose of alteplase (a clot-busting medicine) given into the chest can improve healing of infected pleural fluid when drainage is incomplete. It may help reduce dosing-related side effects while still helping clear the infection-related fluid.
This study tests whether a minimally invasive camera procedure (thoracoscopy) combined with special medications helps treat serious infections in the space around your lungs. The goal is to see if this approach works better than standard drainage alone.
This study tests whether rinsing the infected space around the lung with salt water (saline) before giving enzyme medicine helps clear the infection better than just the enzyme medicine alone. It's for people with a serious lung infection (empyema) that requires a chest tube.
This trial tests a new PCR panel to quickly identify infections in pleural fluid (fluid around the lungs). It may help doctors choose the right treatment faster for people with new fluid buildup in the chest.
This trial tests whether injecting two medications (tPA and DNase) through a chest tube helps treat serious lung infections with fluid buildup. The goal is to see if this approach reduces the need for surgery and helps patients recover faster.
This trial tests a once-daily enzyme treatment given through a chest tube to clear infected fluid from around the lungs. It may help people with complicated pneumonia or empyema who still have fluid buildup after initial drainage.
Hear when a new Pleural Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.